Literature DB >> 25039043

Lipoprotein particle concentrations in children and adults following Kawasaki disease.

Jonathan Lin1, Sonia Jain2, Xiaoying Sun2, Victoria Liu1, Yuichiro Z Sato1, Susan Jimenez-Fernandez1, Ron S Newfield1, Ray Pourfarzib3, Adriana H Tremoulet1, John B Gordon4, Lori B Daniels5, Jane C Burns6.   

Abstract

OBJECTIVE: To test the hypothesis that children and adults with a history of Kawasaki disease (KD) are more likely to have abnormal lipoprotein particle profiles that could place them at increased risk for developing atherosclerosis later in life. STUDY
DESIGN: Fasting serum samples were obtained from 192 children and 63 adults with history of KD and 90 age-similar healthy controls. Lipoprotein particle concentrations and sizes were measured by nuclear magnetic resonance spectroscopy (LipoScience Inc, Raleigh, North Carolina), and serum was assayed for total cholesterol (TC), triglycerides, and high-density lipoprotein (HDL) cholesterol (HDL-C). Low-density lipoprotein (LDL) cholesterol was estimated using the Friedewald formula. Data were analyzed in a least-square means model, with adjustment for age and sex and with the use of Holm correction for multiple comparisons.
RESULTS: Compared with respective control groups, both adult and pediatric subjects with KD had significantly lower mean very low-density lipoprotein-chylomicron particles, intermediate-density lipoproteins, triglycerides, and TC concentrations. Pediatric subjects with KD had significantly lower LDL particle and LDL cholesterol concentrations and lower mean TC/HDL-C ratio (P < .001). In contrast, the adult subjects with KD had significantly lower HDL particle, small HDL particle, and HDL-C concentrations (P < .001), but HDL-C was within normal range.
CONCLUSIONS: Nuclear magnetic resonance lipoprotein particle analysis suggests that pediatric and adult subjects with KD, regardless of their aneurysm status, are no more likely than age-similar, healthy controls to have lipid patterns associated with increased risk of atherosclerosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25039043      PMCID: PMC4207833          DOI: 10.1016/j.jpeds.2014.06.017

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  44 in total

1.  Nationwide survey of Kawasaki disease and acute rheumatic fever.

Authors:  K A Taubert; A H Rowley; S T Shulman
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

2.  Assessing vascular health after Kawasaki disease: a cautionary tale.

Authors:  Jane C Burns; Lori B Daniels
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

3.  Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study.

Authors:  D S Freedman; B A Bowman; J D Otvos; S R Srinivasan; G S Berenson
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

4.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

5.  Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease.

Authors:  A N Chiang; B Hwang; G C Shaw; B C Lee; J H Lu; C C Meng; P Chou
Journal:  Clin Chim Acta       Date:  1997-04-04       Impact factor: 3.786

6.  Coronary artery aneurysms in a young adult: a case of sudden death. A late sequelae of Kawasaki disease?

Authors:  V Fineschi; L Paglicci Reattelli; G Baroldi
Journal:  Int J Legal Med       Date:  1999       Impact factor: 2.686

7.  Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.

Authors:  James D Otvos; Samia Mora; Irina Shalaurova; Philip Greenland; Rachel H Mackey; David C Goff
Journal:  J Clin Lipidol       Date:  2011 Mar-Apr       Impact factor: 4.766

8.  Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?

Authors:  Brian W McCrindle; Susan McIntyre; Christopher Kim; Tammy Lin; Khosrow Adeli
Journal:  J Pediatr       Date:  2007-07-24       Impact factor: 4.406

Review 9.  Kawasaki disease: late cardiovascular sequelae.

Authors:  Lori B Daniels; John B Gordon; Jane C Burns
Journal:  Curr Opin Cardiol       Date:  2012-11       Impact factor: 2.161

10.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

View more
  7 in total

1.  Association of Familial History of Diabetes, Hypertension, Dyslipidemia, Stroke, or Myocardial Infarction With Risk of Kawasaki Disease.

Authors:  Ji Hee Kwak; Eun Kyo Ha; Ju Hee Kim; Hye Ryung Cha; Seung Won Lee; Man Yong Han
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

2.  Prevalence of Coronary Artery Disease Risk Factors and Metabolic Syndrome in Children with Heart Disease.

Authors:  Adam L Ware; Paul C Young; Cindy Weng; Angela P Presson; L LuAnn Minich; Shaji C Menon
Journal:  Pediatr Cardiol       Date:  2017-10-23       Impact factor: 1.655

3.  Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan.

Authors:  Ying-Ju Lin; Jeng-Sheng Chang; Xiang Liu; Hsinyi Tsang; Wen-Kuei Chien; Jin-Hua Chen; Hsin-Yang Hsieh; Kai-Chung Hsueh; Yi-Tzone Shiao; Ju-Pi Li; Cheng-Wen Lin; Chih-Ho Lai; Jer-Yuarn Wu; Chien-Hsiun Chen; Jaung-Geng Lin; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Yu-Ching Lan; Tsung-Jung Ho; Wen-Miin Liang; Yi-Chun Yeh; Jung-Chun Lin; Fuu-Jen Tsai
Journal:  Sci Rep       Date:  2015-10-05       Impact factor: 4.379

4.  Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.

Authors:  Margery A Connelly; Chisato Shimizu; Deborah A Winegar; Irina Shalaurova; Ray Pourfarzib; James D Otvos; John T Kanegaye; Adriana H Tremoulet; Jane C Burns
Journal:  BMC Pediatr       Date:  2016-09-05       Impact factor: 2.125

5.  The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease.

Authors:  Ji-Yong Zhang; Hong Peng; Si-Tang Gong; Yong-Mei Zeng; Miao Huang; Pei-Hui Liu; Li-Ting Wang; Guo-Qing Dong
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 6.  An Update on Cardiovascular Risk Factors After Kawasaki Disease.

Authors:  Yuan-Yuan Zeng; Min Zhang; Syeun Ko; Feng Chen
Journal:  Front Cardiovasc Med       Date:  2021-04-16

Review 7.  Cardiovascular risk in children: a burden for future generations.

Authors:  Maria Candelino; Veronica Maria Tagi; Francesco Chiarelli
Journal:  Ital J Pediatr       Date:  2022-04-11       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.